메뉴 건너뛰기




Volumn 201, Issue 11, 2020, Pages 1324-1325

COVID-19: First do no harm

Author keywords

[No Author keywords available]

Indexed keywords

CORTICOSTEROID; DRUG; HYDROXYCHLOROQUINE; INTERLEUKIN 6 ANTIBODY; REMDESIVIR;

EID: 85084616861     PISSN: 1073449X     EISSN: 15354970     Source Type: Journal    
DOI: 10.1164/rccm.202004-1153ED     Document Type: Editorial
Times cited : (26)

References (14)
  • 2
    • 74749105866 scopus 로고    scopus 로고
    • 1918 influenza: a Winnebago County, Wisconsin perspective
    • Shors T, McFadden SH. 1918 influenza: a Winnebago County, Wisconsin perspective. Clin Med Res 2009;7:147–156.
    • (2009) Clin Med Res , vol.7 , pp. 147-156
    • Shors, T1    McFadden, SH.2
  • 3
    • 85083246188 scopus 로고    scopus 로고
    • Clinical features of 85 fatal cases of COVID-19 from Wuhan: a retrospective observational study
    • Du Y, Tu L, Zhu P, Mu M, Wang R, Yang P, et al. Clinical features of 85 fatal cases of COVID-19 from Wuhan: a retrospective observational study. Am J Respir Crit Care Med 2020;201:1372–1379.
    • (2020) Am J Respir Crit Care Med , vol.201 , pp. 1372-1379
    • Du, Y1    Tu, L2    Zhu, P3    Mu, M4    Wang, R5    Yang, P6
  • 4
    • 85083299255 scopus 로고    scopus 로고
    • Cardiac and arrhythmic complications in patients with COVID-19
    • [online ahead of print] 9 Apr 2020
    • Kochi AN, Tagliari AP, Forleo GB, Fassini GM, Tondo C. Cardiac and arrhythmic complications in patients with COVID-19. J Cardiovasc Electrophysiol [online ahead of print] 9 Apr 2020; DOI: 10.1111/ jce.14479.
    • J Cardiovasc Electrophysiol
    • Kochi, AN1    Tagliari, AP2    Forleo, GB3    Fassini, GM4    Tondo, C.5
  • 5
    • 85059523058 scopus 로고    scopus 로고
    • IL-6 inhibitor for the treatment of rheumatoid arthritis: a comprehensive review
    • Ogata A, Kato Y, Higa S, Yoshizaki K. IL-6 inhibitor for the treatment of rheumatoid arthritis: a comprehensive review. Mod Rheumatol 2019;29:258–267.
    • (2019) Mod Rheumatol , vol.29 , pp. 258-267
    • Ogata, A1    Kato, Y2    Higa, S3    Yoshizaki, K.4
  • 6
    • 84978371339 scopus 로고    scopus 로고
    • Cytomegalovirus reactivation induced acute hepatitis and gastric erosions in a patient with rheumatoid arthritis under treatment with an anti-IL-6 receptor antibody, tocilizumab
    • Komura T, Ohta H, Nakai R, Seishima J, Yamato M, Miyazawa M, et al. Cytomegalovirus reactivation induced acute hepatitis and gastric erosions in a patient with rheumatoid arthritis under treatment with an anti-IL-6 receptor antibody, tocilizumab. Intern Med 2016;55: 1923–1927.
    • (2016) Intern Med , vol.55 , pp. 1923-1927
    • Komura, T1    Ohta, H2    Nakai, R3    Seishima, J4    Yamato, M5    Miyazawa, M6
  • 7
    • 85052101199 scopus 로고    scopus 로고
    • Corticosteroid treatment in critically ill patients with severe influenza pneumonia: a propensity score matching study
    • GETGAG Study Group
    • Moreno G, Rodríguez A, Reyes LF, Gomez J, Sole-Violan J, Díaz E, et al.; GETGAG Study Group. Corticosteroid treatment in critically ill patients with severe influenza pneumonia: a propensity score matching study. Intensive Care Med 2018;44: 1470–1482.
    • (2018) Intensive Care Med , vol.44 , pp. 1470-1482
    • Moreno, G1    Rodríguez, A2    Reyes, LF3    Gomez, J4    Sole-Violan, J5    Díaz, E6
  • 8
    • 85063588974 scopus 로고    scopus 로고
    • The effect of corticosteroids on mortality of patients with influenza pneumonia: a systematic review and meta-analysis
    • Ni YN, Chen G, Sun J, Liang BM, Liang ZA. The effect of corticosteroids on mortality of patients with influenza pneumonia: a systematic review and meta-analysis. Crit Care 2019;23:99.
    • (2019) Crit Care , vol.23 , pp. 99
    • Ni, YN1    Chen, G2    Sun, J3    Liang, BM4    Liang, ZA.5
  • 9
    • 85083865576 scopus 로고    scopus 로고
    • COVID-19 with different severities: a multicenter study of clinical features
    • Feng Y, Ling Y, Bai T, Xie Y, Huang J, Li J, et al. COVID-19 with different severities: a multicenter study of clinical features. Am J Respir Crit Care Med 2020;201:1380–1388.
    • (2020) Am J Respir Crit Care Med , vol.201 , pp. 1380-1388
    • Feng, Y1    Ling, Y2    Bai, T3    Xie, Y4    Huang, J5    Li, J6
  • 10
    • 85083241288 scopus 로고    scopus 로고
    • COVID-19 does not lead to a “typical” acute respiratory distress syndrome
    • [online ahead of print] 30 Mar 2020
    • Gattinoni L, Coppola S, Cressoni M, Busana M, Rossi S, Chiumello D. COVID-19 does not lead to a “typical” acute respiratory distress syndrome. Am J Respir Crit Care Med [online ahead of print] 30 Mar 2020; DOI: 10.1164/rccm.202003-0817LE.
    • Am J Respir Crit Care Med
    • Gattinoni, L1    Coppola, S2    Cressoni, M3    Busana, M4    Rossi, S5    Chiumello, D.6
  • 11
    • 85083268551 scopus 로고    scopus 로고
    • The pathogenesis and treatment of the ‘Cytokine storm’ in COVID-19
    • [online ahead of print] 10 Apr 2020
    • Ye Q, Wang B, Mao J. The pathogenesis and treatment of the ‘Cytokine storm’ in COVID-19. J Infect [online ahead of print] 10 Apr 2020; DOI: 10.1016/j.jinf.2020.03.037.
    • J Infect
    • Ye, Q1    Wang, B2    Mao, J.3
  • 12
    • 85086346057 scopus 로고    scopus 로고
    • Compassionate use of remdesivir for patients with severe Covid-19
    • [online ahead of print] 10 Apr 2020
    • Grein J, Ohmagari N, Shin D, Diaz G, Asperges E, Castagna A, et al. Compassionate use of remdesivir for patients with severe Covid-19. N Engl J Med [online ahead of print] 10 Apr 2020; DOI: 10.1056/NEJMoa2007016.
    • N Engl J Med
    • Grein, J1    Ohmagari, N2    Shin, D3    Diaz, G4    Asperges, E5    Castagna, A6
  • 13
    • 85084331389 scopus 로고    scopus 로고
    • Optimizing the trade-off between learning and doing in a pandemic
    • [online ahead of print] 30 Mar 2020
    • Angus DC. Optimizing the trade-off between learning and doing in a pandemic. JAMA [online ahead of print] 30 Mar 2020; DOI: 10.1001/jama.2020.4984.
    • JAMA
    • Angus, DC.1
  • 14
    • 85087186298 scopus 로고    scopus 로고
    • The randomized embedded multifactorial adaptive platform for community-acquired pneumonia (REMAP-CAP) study: rationale and design
    • [online ahead of print] 8 Apr 2020
    • Angus DC, Berry S, Lewis RJ, Al-Beidh F, Arabi Y, van Bentum-Puijk W, et al. The randomized embedded multifactorial adaptive platform for community-acquired pneumonia (REMAP-CAP) study: rationale and design. Ann Am Thorac Soc [online ahead of print] 8 Apr 2020; DOI: 10.1513/AnnalsATS.202003-192SD.
    • Ann Am Thorac Soc
    • Angus, DC1    Berry, S2    Lewis, RJ3    Al-Beidh, F4    Arabi, Y5    van Bentum-Puijk, W6


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.